81 related articles for article (PubMed ID: 26811867)
1. Second surgery for recurrent glioblastoma: A concise overview of the current literature.
Montemurro N; Perrini P; Blanco MO; Vannozzi R
Clin Neurol Neurosurg; 2016 Mar; 142():60-64. PubMed ID: 26811867
[TBL] [Abstract][Full Text] [Related]
2. Associations between recurrence patterns and outcome in glioblastoma patients undergoing re-resection: A complementary report of the RANO resect group.
Karschnia P; Dono A; Young JS; Juenger ST; Teske N; Häni L; Sciortino T; Mau CY; Bruno F; Nunez L; Morshed RA; Haddad AF; Weller M; van den Bent M; Thon N; Beck J; Hervey-Jumper S; Molinaro AM; Tandon N; Rudà R; Vogelbaum MA; Bello L; Schnell O; Grau SJ; Chang SM; Berger MS; Esquenazi Y; Tonn JC
Neuro Oncol; 2024 Mar; 26(3):584-586. PubMed ID: 38164632
[No Abstract] [Full Text] [Related]
3. Therapeutic options in recurrent glioblastoma--An update.
Seystahl K; Wick W; Weller M
Crit Rev Oncol Hematol; 2016 Mar; 99():389-408. PubMed ID: 26830009
[TBL] [Abstract][Full Text] [Related]
4. Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma-results from the DIRECTOR trial.
Suchorska B; Weller M; Tabatabai G; Senft C; Hau P; Sabel MC; Herrlinger U; Ketter R; Schlegel U; Marosi C; Reifenberger G; Wick W; Tonn JC; Wirsching HG
Neuro Oncol; 2016 Apr; 18(4):549-56. PubMed ID: 26823503
[TBL] [Abstract][Full Text] [Related]
5. Outcomes after second surgery for recurrent glioblastoma: a retrospective case-control study.
Wann A; Tully PA; Barnes EH; Lwin Z; Jeffree R; Drummond KJ; Gan H; Khasraw M
J Neurooncol; 2018 Apr; 137(2):409-415. PubMed ID: 29294233
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of a prognostic model for recurrent glioblastoma patients treated with bevacizumab and irinotecan.
Urup T; Dahlrot RH; Grunnet K; Christensen IJ; Michaelsen SR; Toft A; Larsen VA; Broholm H; Kosteljanetz M; Hansen S; Poulsen HS; Lassen U
Acta Oncol; 2016; 55(4):418-22. PubMed ID: 26828563
[TBL] [Abstract][Full Text] [Related]
7. Treatment options for recurrent high-grade gliomas.
Birk HS; Han SJ; Butowski NA
CNS Oncol; 2017 Jan; 6(1):61-70. PubMed ID: 28001091
[TBL] [Abstract][Full Text] [Related]
8. Survival in glioblastoma: a review on the impact of treatment modalities.
Delgado-López PD; Corrales-García EM
Clin Transl Oncol; 2016 Nov; 18(11):1062-1071. PubMed ID: 26960561
[TBL] [Abstract][Full Text] [Related]
9. Patient outcomes following second surgery for recurrent glioblastoma.
Brandes AA; Bartolotti M; Tosoni A; Poggi R; Bartolini S; Paccapelo A; Bacci A; Ghimenton C; Pession A; Bortolotti C; Zucchelli M; Galzio R; Talacchi A; Volpin L; Marucci G; de Biase D; Pizzolitto S; Danieli D; Ermani M; Franceschi E
Future Oncol; 2016; 12(8):1039-44. PubMed ID: 26880307
[TBL] [Abstract][Full Text] [Related]
10. The benefit of surgical resection in recurrent glioblastoma.
Vogelbaum MA
Neuro Oncol; 2016 Apr; 18(4):462-3. PubMed ID: 26869588
[No Abstract] [Full Text] [Related]
11. Targeting NF-κB in glioblastoma: A therapeutic approach.
Friedmann-Morvinski D; Narasimamurthy R; Xia Y; Myskiw C; Soda Y; Verma IM
Sci Adv; 2016 Jan; 2(1):e1501292. PubMed ID: 26824076
[TBL] [Abstract][Full Text] [Related]
12. Reoperation for Recurrent Glioblastoma Multiforme.
Robin AM; Lee I; Kalkanis SN
Neurosurg Clin N Am; 2017 Jul; 28(3):407-428. PubMed ID: 28600015
[TBL] [Abstract][Full Text] [Related]
13. Resection of recurrent glioblastoma multiforme in elderly patients: a pseudo-randomized analysis revealed clinical benefit.
Fariña Nuñez MT; Franco P; Cipriani D; Neidert N; Behringer SP; Mader I; Delev D; Fung C; Beck J; Sankowski R; Nicolay NH; Heiland DH; Schnell O
J Neurooncol; 2020 Jan; 146(2):381-387. PubMed ID: 31933259
[TBL] [Abstract][Full Text] [Related]
14. Survival outcomes following repeat surgery for recurrent glioblastoma: a single-center retrospective analysis.
Perrini P; Gambacciani C; Weiss A; Pasqualetti F; Delishaj D; Paiar F; Morganti R; Vannozzi R; Lutzemberger L
J Neurooncol; 2017 Feb; 131(3):585-591. PubMed ID: 27844310
[TBL] [Abstract][Full Text] [Related]
15. The Survival Effect of Repeat Surgery at Glioblastoma Recurrence and its Trend: A Systematic Review and Meta-Analysis.
Lu VM; Jue TR; McDonald KL; Rovin RA
World Neurosurg; 2018 Jul; 115():453-459.e3. PubMed ID: 29654958
[TBL] [Abstract][Full Text] [Related]
16. Management of glioblastoma: State of the art and future directions.
Tan AC; Ashley DM; López GY; Malinzak M; Friedman HS; Khasraw M
CA Cancer J Clin; 2020 Jul; 70(4):299-312. PubMed ID: 32478924
[TBL] [Abstract][Full Text] [Related]
17. Survival benefit of surgery in recurrent glioblastoma multiforme.
Choudry UK; Khan SA; Shamim MS
J Pak Med Assoc; 2017 Dec; 67(12):1951-1953. PubMed ID: 29256553
[TBL] [Abstract][Full Text] [Related]
18. Tumour growth rate predicts overall survival in patients with recurrent WHO grade 4 glioma.
Pang JHW; Saffari SE; Lee GR; Yu WY; Lim CCT; Lim KC; Lee CC; Koh WY; Chia WTD; Chua KLM; Tham CK; Low YYS; Ng WH; Low CYD; Lin X
BMC Med Imaging; 2024 May; 24(1):125. PubMed ID: 38802734
[TBL] [Abstract][Full Text] [Related]
19. Recurrent Glioblastoma: A Review of the Treatment Options.
Vaz-Salgado MA; Villamayor M; Albarrán V; Alía V; Sotoca P; Chamorro J; Rosero D; Barrill AM; Martín M; Fernandez E; Gutierrez JA; Rojas-Medina LM; Ley L
Cancers (Basel); 2023 Aug; 15(17):. PubMed ID: 37686553
[TBL] [Abstract][Full Text] [Related]
20. Recurrent high grade glioma surgery with carmustine wafers implantation: a long-term nationwide retrospective study.
Champeaux-Depond C; Jecko V; Weller J; Constantinou P; Tuppin P; Metellus P
J Neurooncol; 2023 Apr; 162(2):343-352. PubMed ID: 36991304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
